Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
World J Hepatol
256 - 260.
The presence of CD8 T cell responses to tumor associated antigens have been reported in patients with different malignancies. However, there is very little information on a comparable CD8 and CD4 T cell response to a tumor antigen in liver cancer patients. Here, we re-examine the kinetic and the pattern of T helper 1 and cytotoxic T lymphocyte responses to alpha-fetoprotein (AFP), a tumor rejection antigen in hepatocellular carcinoma (HCC). Then, we discuss the possibility of using AFP-based immunotherapy in combination with necrotizing treatments in HCC patients.
|Title:||Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.|
|Open access status:||An open access publication|
|Keywords:||Alpha-fetoprotein, Cell-mediated immunity, Hepatocellular carcinoma, Immunotherapy|
Archive Staff Only